MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/ph18060800

Медицинская библиотека · Pharmaceuticals (Basel, Switzerland) · 2025

Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management.

Wahood Samer, Alani Omar, Draw Iyla, Shqair Lara, Wang David, Bunick Christopher G, Damiani Giovanni, Ho Jonathan D, Obagi Sabine, Akbarialiabad Hossein, Galimberti Fabrizio, Ghannoum Mahmoud, Grada Ayman

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Background

Fluoroquinolones, available in topical and oral formulations, are used to manage bacterial skin and soft tissue infections, including Pseudomonas aeruginosa, atypical mycobacteria, and select multidrug-resistant Gram-negative organisms. Their excellent tissue penetration, bactericidal activity, and convenient dosing make them effective for certain skin and soft tissue infections. However, their use is limited by potential safety concerns, including tendinopathy (odds ratio up to 9.1 in corticosteroid users), QT interval prolongation with risk of torsades de pointes, phototoxicity, and rising antimicrobial resistance.

Methods

A literature search of PubMed, Scopus, and Web of Science was conducted for articles from January 1985 to April 2025 with the search terms (quinolone OR fluoroquinolone) AND (dermatology OR "skin and soft tissue infection" OR "skin structure infection"). Abstracts and presentations were excluded. A Google search used the same terms for articles from government regulatory agencies.

Results

This review provides practical guidance on the clinical use of topical and oral fluoroquinolones in dermatology. Delafloxacin demonstrated over 90% cure rates in trials for complicated skin infections. However, serious safety concerns remain, including a ninefold increase in tendinopathy risk among older adults on corticosteroids and corrected QT intervals exceeding 500 milliseconds in high-risk patients. Phototoxicity varies, with agents like sparfloxacin linked to heightened ultraviolet sensitivity. Resistance to ciprofloxacin exceeds 20 percent in Escherichia coli and P. aeruginosa in some populations. Culture-based prescribing, shorter treatment courses, and preference for topical treatments can reduce risk and preserve efficacy.

Conclusions

Fluoroquinolones remain clinically useful in dermatology when prescribed selectively. Their appropriate use requires careful attention to patient risk factors along with their evolving resistance patterns and ongoing stewardship efforts.

Для цитирования: Wahood Samer, Alani Omar, Draw Iyla, Shqair Lara, Wang David, Bunick Christopher G, Damiani Giovanni, Ho Jonathan D, Obagi Sabine, Akbarialiabad Hossein, Galimberti Fabrizio, Ghannoum Mahmoud, Grada Ayman. Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management.. Pharmaceuticals (Basel, Switzerland). 2025. DOI: 10.3390/ph18060800.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.